Friday, November 13, 2026

Dollar Index Crashes 10.8% as Federal Reserve Leadership Void Triggers Global Currency Turmoil

The U.S. Dollar Index has plunged 10.8% in early 2026 to its lowest level since 2022 as markets confront the Federal Reserve's June leadership transition. The crisis is radiating across global markets, with sterling falling toward $1.30, Swiss franc safe-haven flows surging, and gold breaching $4,100 per ounce.

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
Dollar Index Crashes 10.8% as Federal Reserve Leadership Void Triggers Global Currency Turmoil
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The U.S. Dollar Index has crashed 10.8% in early 2026, hitting its lowest level since 2022 as the Federal Reserve's June leadership transition creates a policy vacuum that is destabilizing global currency markets.

Safe-haven flows into the Swiss franc and gold's surge past $4,100 per ounce signal deepening systemic concerns about monetary policy continuity at the world's most powerful central bank. Currency analysts forecast sustained volatility through the transition, as market participants lack clarity on the incoming chair's stance on interest rates and quantitative tightening.

The sterling fell 0.5% to $1.3086 on Wednesday despite gaining 7% against the dollar in 2025, pressured by UK fiscal uncertainty ahead of Chancellor Rachel Reeves' November 26 budget. Jordan Rochester at Mizuho Bank warned the pound could break below $1.30 if gilt concerns intensify. UK 30-year gilt yields climbed 4 basis points to 5.21%, the highest since 1998.

Simon Phillips, managing director at No1 Currency, noted the pound faces dual headwinds as UK borrowing costs rise alongside dollar weakness. Neil Wilson at Saxo Markets highlighted risks of fiscal instability spreading across developed economies, with rising government debt costs in Britain and Europe compounding currency pressures.

The dollar collapse is supporting commodity prices globally. WTI crude rose 1.5% to around $61 per barrel on Tuesday, while precious metals attract investors fleeing dollar-denominated assets.

The Fed leadership change represents the most significant central bank transition since Jerome Powell's appointment, with implications for international monetary policy coordination. Markets are repricing portfolios to hedge against potential policy shifts as current leadership enters its final months without clear signals from the incoming administration.

Currency desks worldwide are positioning for heightened volatility through mid-2026 as the transition creates uncertainty across global forex, commodity, and bond markets. The policy vacuum at the Fed is reshaping capital flows across continents.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 7, 2026
    Ray Dalio says America is facing a ‘debt death spiral’ — but you can protect your portfolio with these 3 assets
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com